Angiogenic potential of malignant and non-malignant human breast tissues in an in vivo angiogenesis model

被引:2
|
作者
Lichtenbeld, HC
Barendsz-Janson, AF
van Essen, H
Boudier, HS
Griffioen, AW
Hillen, HFP
机构
[1] Acad Hosp Maastricht, Dept Internal Med, NL-6202 AZ Maastricht, Netherlands
[2] Univ Maastricht, Dept Pharmacol, Maastricht, Netherlands
关键词
D O I
10.1002/(SICI)1097-0215(19980729)77:3<455::AID-IJC23>3.3.CO;2-C
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumors need to acquire an angiogenic phenotype for outgrowth and metastasis formation. Limited information on the angiogenic potential of specific tissues, especially human breast tissues is available. Here we describe an in vivo model, using the dorsal skin fold chamber in immunodeficient nude mice, where various tissues of human breast origin were xenografted and evaluated for their angiogenesis-inducing potential. We found that angiogenesis was abundantly induced by all breast carcinoma tissue samples, Similar angiogenesis was induced by tissue samples from breasts with hyperplasia and apocrine metaplasia, Histologically normal tissues adjacent to the tumor induced angiogenesis in 66% of the cases. Angiogenesis was not induced by control tissues from normal healthy breasts, obtained after cosmetic breast reduction. Angiogenesis induction parallelled VEGF production by the tumor cells, The tissue induced neovascularization, found both around and in the human tissue, was functional since a tail vein injection of albumin-FITC revealed positive tumor microcirculation within 5 min, while the tumor tissue still consisted of vital human epithelial cells after 14 days. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 50 条
  • [41] Neurological manifestations of malignant and non-malignant dysglobulinaemias
    Andreas J. Steck
    Journal of Neurology, 1998, 245 : 634 - 639
  • [42] LEUCOCYTOTOXICITY IN MALIGNANT AND NON-MALIGNANT COLONIC DISEASES
    VOSE, BM
    MOORE, M
    SCHOFIELD, PF
    DYMOCK, IW
    BRITISH JOURNAL OF CANCER, 1975, 32 (02) : 244 - 245
  • [43] HA-RAS ONCOGENE EXPRESSION IN NON-MALIGNANT HUMAN-BREAST
    HILDEBRANDT, R
    LONGACRE, T
    WILLMAN, C
    BARTOW, S
    MODERN PATHOLOGY, 1988, 1 (01) : A39 - A39
  • [44] HA-RAS ONCOGENE EXPRESSION IN NON-MALIGNANT HUMAN-BREAST
    HILDEBRANDT, R
    LONGACRE, T
    WILLMAN, C
    BARTOW, S
    LABORATORY INVESTIGATION, 1988, 58 (01) : A39 - A39
  • [46] Lipid peroxidation and antioxidants status in human malignant and non-malignant thyroid tumours
    Stanley, J. A.
    Neelamohan, R.
    Suthagar, E.
    Vengatesh, G.
    Jayakumar, J.
    Chandrasekaran, M.
    Banu, S. K.
    Aruldhas, M. M.
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2016, 35 (06) : 585 - 597
  • [47] CHARACTERIZATION OF HUMAN UROTHELIAL CELL-LINES OF NON-MALIGNANT AND MALIGNANT ORIGIN
    CHRISTENSEN, B
    KIELER, J
    DON, P
    VILIEN, M
    WOLF, H
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (09): : 1277 - 1277
  • [48] ASPARAGINE SYNTHETASE ACTIVITY IN MALIGNANT AND NON-MALIGNANT HUMAN KIDNEY AND PROSTATE SPECIMENS
    PRAGER, MD
    PETERS, PC
    JANES, JO
    DERR, I
    NATURE, 1969, 221 (5185) : 1064 - &
  • [49] Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines
    Abudabbus, Aisha
    Badmus, Jelili A.
    Shalaweh, Salem
    Bauer, Rolene
    Hiss, Donavon
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (09) : 748 - 757
  • [50] Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues
    Sóñora, C
    Mazal, D
    Berois, N
    Buisine, MP
    Ubillos, L
    Varangot, M
    Barrios, E
    Carzoglio, J
    Aubert, JP
    Osinaga, E
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2006, 54 (03) : 289 - 299